May 2, 2018 / 8:17 PM / 3 months ago

BRIEF-Exelixis And Invenra Enter Into Collaboration To Develop Novel Biologics To Treat Cancer

May 2 (Reuters) - Exelixis Inc:

* EXELIXIS AND INVENRA ENTER INTO COLLABORATION TO DISCOVER AND DEVELOP NOVEL BIOLOGICS TO TREAT CANCER

* EXELIXIS INC - COMPANIES WILL PARTNER TO ADVANCE MULTISPECIFIC ANTIBODIES IN UP TO SEVEN DISCRETE PROJECTS

* EXELIXIS INC - EXELIXIS WILL PAY INVENRA AN UPFRONT PAYMENT OF $2.0 MILLION PLUS $2.0 MILLION AT INITIATION OF EACH DISCOVERY PROJECT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below